Jun 12 |
Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club
|
Jun 11 |
Regeneron wins injunction blocking Mylan from launching generic version of its eye drug Eylea (update)
|
Jun 11 |
Regeneron (REGN), SNY Win FDA Nod for Kevzara Label Expansion
|
Jun 11 |
Regeneron Pharmaceuticals, Inc. (REGN) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
|
Jun 11 |
Regeneron, Sanofi win FDA label expansion for arthritis therapy Kevzara
|
Jun 11 |
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)
|
Jun 8 |
Is Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock's Recent Performance A Reflection Of Its Financial Health?
|
Jun 7 |
Stock Split Watch: 3 Growth Stocks That Could Be Next
|
Jun 5 |
Regeneron Pharmaceuticals, Inc. (REGN) Management presents at Jefferies 2024 Global Healthcare Conference (Transcript)
|
Jun 4 |
Health Care Stocks Show Relative Strength as S&P 500 Stalls
|